Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q4 EPS of $0.11, $0.08 better than the analyst estimate of $0.03. Revenue for the quarter came in at $93 million versus the consensus estimate of $85.56 million.

GUIDANCE:

Cellebrite DI Ltd. sees FY 2024 revenue of $370-380 million, versus the consensus of $370.7 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.